Botox

(redirected from onabotulinum toxin A)
Also found in: Thesaurus, Medical, Encyclopedia.

Bo·tox

 (bō′tŏks′)
A trademark for a preparation of botulinum toxin, used to treat blepharospasms, strabismus, and muscle dystonias and to smooth facial wrinkles.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

Botox

(ˈbəʊtɒks)
n
(Medicine) trademark a preparation of botulinum toxin used to treat muscle spasm and to remove wrinkles
[C20: from bot(ulinum) (t)ox(in)]
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.Botox - a neurotoxin (trade name Botox) that is used clinically in small quantities to treat strabismus and facial spasms and other neurological disorders characterized by abnormal muscle contractions; is also used by cosmetic surgeons to smooth frown lines temporarily
botulinum toxin - any of several neurotoxins that are produced by the anaerobic bacterium Clostridium botulinum; causes muscle paralysis
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

Botox®

[ˈbəʊtɒks] nBotox m
Botox injections → injections fpl de Botox
Collins English/French Electronic Resource. © HarperCollins Publishers 2005

Botox®

nBotox® nt; she uses Botoxsie lässt sich Botox spritzen
Collins German Dictionary – Complete and Unabridged 7th Edition 2005. © William Collins Sons & Co. Ltd. 1980 © HarperCollins Publishers 1991, 1997, 1999, 2004, 2005, 2007

botox

n. bótox, proteína purificada por la bacteria de botulismo clostridium que se emplea en aplicaciones cosméticas.
English-Spanish Medical Dictionary © Farlex 2012
References in periodicals archive ?
We identified a prospective cohort of patients with neurogenic bladder who were undergoing their first intravesical injection of onabotulinum toxin A for neurogenic detrusor overactivity between December 2014-December 2016.(4) A convenience sample was used, given a lack of formal methods to determine sample size in responsiveness studies.
Using the total intravesical onabotulinum toxin A patient cohort, a paired t-test (mean NBSS domain score at baseline compared to mean NBSS domain score follow-up), standardized effect size (SES), and standardized response mean (SRM) was calculated.(7) A statistically significant change in the NBSS domain score, or a moderate (>0.5) SES or SRM was defined a priori as significant evidence of responsiveness.(7) The second method was an anchor based approach that uses the global assessment of change score to define a clinically relevant change.
In the period 2014-2015, a retrospective data analysis was made of the data of 25 female patients who underwent onabotulinum toxin A (Botox, Allergan, Inc., Irvine, CA, USA) injections into the masseter muscle for clinically diagnosed nocturnal bruxism.
For all patients, 100 mouse units (MU) of onabotulinum toxin A (Botox, Allergan, Inc., Irvine, CA) were diluted in 2 ml of saline.
In January 2013, the FDA expanded the approved use of onabotulinum toxin A (Botox, Allergan) for the treatment of OAB in those who are intolerant of or have failed treatment with anticholinergic medications.
In a recent systematic review and meta-analysis, the authors concluded onabotulinum toxin A to be effective in the treatment of idiopathic OAB with a statistically significant reduction compared with baseline in the number of incontinence episodes per day (-2.77 in the treatment group vs -1.01 in the placebo group) and the number of voids per day (-1.61 in the treatment group vs -0.87 in the placebo group).
Onabotulinum toxin A for refractory cases provides an important therapeutic alternative.
Key Words: Onabotulinum toxin A, urinary bladder, overactive bladder, neurogenic bladder, neurogenic detrusor overactivity.
Popularly known as a cosmetic agent for chemical face and neck rejuvenation, onabotulinum toxin A (Botox[R]) reduces wrinkles by targeting their major cause, the facial muscles (Felber, 2006).
Consistent and durable improvements in quality of life with long-term onabotulinum toxin A treatment in patients with overactive bladder